Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gatifloxacin - Allergan/Senju Pharmaceutical

Drug Profile

Gatifloxacin - Allergan/Senju Pharmaceutical

Alternative Names: AM 1155; BMS 206584; Bonoq; Bonoq Uro; CG 5501; Gatiflo; Gesetz; Tequin; Zymar; Zymaxid

Latest Information Update: 02 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kyorin Pharmaceutical
  • Developer Allergan; Kyorin Pharmaceutical; Senju Pharmaceutical
  • Class Antibacterials; Fluoroquinolones; Small molecules
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Infectious conjunctivitis
  • Market Withdrawal Acute exacerbations of chronic bronchitis; Bacterial infections; Chlamydial infections; Gonorrhoea; Pneumonia; Respiratory tract infections; Sinusitis; Skin and soft tissue infections; Urinary tract infections
  • Discontinued Anthrax; Otitis media

Most Recent Events

  • 02 Jul 2019 No development reported - Preregistration for Infectious conjunctivitis in China (Ophthalmic)
  • 06 Feb 2017 Gatifloxacin is still in under Preregistration for Infectious conjunctivitis in China (Ophthalmic)
  • 19 Jun 2014 Dainippon Sumitomo Pharma is now called Sumitomo Dainippon Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top